CXCL10 and breast carcinoma: In the next step, we employed a wound healing assay to evaluate whether CXCL10 promotes breast cancer cell migration in MCF-7 and MDA-MB-231 by observing cell migration after 24 h and 48 h of CXCL10 treatment.